Awarded scholarships

$ 2,000 scholarship awarded to Andrei Ciobanu

Andrei graduated from medical school and specialized in anesthesia in Moldova. Since then, he has pursued a master’s degree in biomedical sciences at the Université de Montréal and the Department of Ophthalmology at Maisonneuve-Rosemont Hospital.

Project: The objective of this project was to evaluate the efficacy of GDx (a three-dimensional retinal nerve fiber camera) for the detection of glaucoma in populations at risk. The subjects underwent a series of examinations including a visual field, a GDx and a complete clinical examination of the eye. Several combinations of examinations have been established and classified according to their effectiveness in detecting glaucoma. This study concludes that GDx may be a useful tool for detecting glaucoma in populations at risk.

$ 10,000 scholarship awarded to Alvine Kamdeu Fansi.

Alvine completed her medical studies and practiced medicine in Burundi. She obtained a Master’s Degree in Biomedical Engineering and is currently completing her PhD in biomedical sciences at the Université de Montréal. She works in clinical research in the fields of medical imaging, telemedicine and ophthalmic screening. (Her research interests revolve around the creation of programs to combat glaucoma and prevent blindness.)

ProjectIt has been demonstrated that anatomical and morphological changes in the optic nerve generally precede visual field loss, which is only noticeable when glaucoma is advanced. Thus, evaluation of the head of the optic nerve is one of the most important screening tests. This project aims to validate and develop new modalities and structures for the detection of glaucoma in order to reduce irreversible damage, including blindness, through early management of the disease. These modalities would not only involve and collaborate with front-line health professionals (optometrists, family physicians), but also offer expertise from glaucoma specialists to the population of remote regions and areas Even in developing countries in the form of telemedicine.

$ 15,000 scholarship awarded to the following four candidates (working on the same project):

Denise Descovich is a graduate ophthalmologist outside Quebec who works with Dr. Mark Lesk at the Maisonneuve-Rosemont Hospital Research Center. She has been interested for several years in the blood flow ocular. Her most recent project involves the search for phenotypes (in genetics: observable traits of a living organism) involved in the development of glaucoma.

Renaud Manuguerra-Gagné is a doctoral student in biomedical sciences at the Université de Montréal. His project, co-directed with Dr. Denis-Claude Roy, focuses on the differentiation of stem cells into trabecular cells to develop a treatment for open-angle glaucoma.

Olivier Fontaine pursued his studies at the doctoral level in the laboratory of Dr. Mark R.Lesk after acquiring initial training in optometry. His research focuses on the retinal and choroidal circulation in both humans and animals.

Jing Wang completed her medical studies at McGill University. Currently, she pursues her residency in ophthalmology at the Université de Sherbrooke and is a doctoral candidate in biomedical sciences at the Université de Montréal.

Project: Recent studies that observe how IOP modifies the anatomical structure of the eye have determined that the more elastic the sclera of the eye, the more sensitive the anatomical stress is to the head of the optic nerve. According to these studies, the elasticity of the sclera would be the major factor that determines the damage caused by glaucoma on the optic nerve. This project involves a clinical evaluation of the biomechanical factors of the eye (eg elasticity and sclera thickness) to determine the correlation between the degree of optic nerve damage caused by glaucoma in relation to these factors. A range of biomechanical eye factors of 300 subjects will be measured as well as the degree of damage to the optic nerve. If there is a correlation, it will validate the factors that play a role in the damage caused. In addition, these data can be used to determine the probable degree of glaucoma evolution in a patient and thus adjust its treatment.